Connecting you to content on EBSCOhost

Works by Pan, Hui-Rong

Results: 5

1

Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.

Published in:

Emerging Microbes & Infections, 2021, v. 10, n. 1, p. 365, doi. 10.1080/22221751.2021.1891002

By:

Zhuang, Chun-Lan;
Lin, Zhi-Jie;
Bi, Zhao-Feng;
Qiu, Ling-Xian;
Hu, Fang-Fang;
Liu, Xiao-Hui;
Lin, Bi-Zhen;
Su, Ying-Ying;
Pan, Hui-Rong;
Zhang, Tian-Ying;
Huang, Shou-Jie;
Hu, Yue-Mei;
Qiao, You-Lin;
Zhu, Feng-Cai;
Wu, Ting;
Zhang, Jun;
Xia, Ning-Shao

Publication type:

Article

2

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial.

Published in:

Human Vaccines & Immunotherapeutics, 2022, v. 18, n. 6, p. 1, doi. 10.1080/21645515.2022.2092363

By:

Mo, Zhao-Jun;
Bi, Zhao-Feng;
Sheng, Wei;
Chen, Qi;
Huang, Teng;
Li, Ming-Qiang;
Cui, Xue-Lian;
Wangjiang, Ya-Hui;
Lin, Bi-Zhen;
Zheng, Feng-Zhu;
Sun, Guang;
Li, Ya-Fei;
Zheng, Ya;
Zhuang, Si-Jie;
Su, Ying-Ying;
Pan, Hui-Rong;
Huang, Shou-Jie;
Wu, Ting;
Zhang, Jun;
Xia, Ning-Shao

Publication type:

Article

3

Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.

Published in:

Human Vaccines & Immunotherapeutics, 2020, v. 16, n. 7, p. 1630, doi. 10.1080/21645515.2020.1761202

By:

Yu, Xiao-Juan;
Li, Juan;
Lin, Zhi-Jie;
Zhao, Hui;
Lin, Bi-Zhen;
Qiao, You-Lin;
Hu, Yue-Mei;
Wei, Li-Hui;
Li, Rong-Cheng;
Huang, Wei-Dan;
Wu, Ting;
Huang, Shou-Jie;
Li, Chang-Gui;
Pan, Hui-Rong;
Zhang, Jun

Publication type:

Article

4

Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.

Published in:

Human Vaccines & Immunotherapeutics, 2020, v. 16, n. 7, p. 1636, doi. 10.1080/21645515.2019.1691413

By:

Su, Ying-Ying;
Lin, Bi-Zhen;
Zhao, Hui;
Li, Juan;
Lin, Zhi-Jie;
Qiao, You-Lin;
Wei, Li-Hui;
Hu, Yue-Mei;
Li, Rong-Cheng;
Zhuang, Si-Jie;
Sun, Guang;
Zheng, Zi-Zheng;
Huang, Shou-Jie;
Wu, Ting;
Zhang, Jun;
Pan, Hui-Rong;
Li, Chang-Gui

Publication type:

Article

5

Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women.

Published in:

SCIENCE CHINA Life Sciences, 2020, v. 63, n. 4, p. 582, doi. 10.1007/s11427-019-9547-7

By:

Hu, Yue-Mei;
Guo, Meng;
Li, Chang-Gui;
Chu, Kai;
He, Wen-Gang;
Zhang, Jing;
Gu, Jian-Xiang;
Li, Juan;
Zhao, Hui;
Wu, Xiang-Hong;
Lin, BiZhen;
Lin, Zhi-Jie;
Yao, Xing-Mei;
Li, Ya-Fei;
Wei, FeiXue;
Huang, Yue;
Su, Ying-Ying;
Zhu, Feng-Cai;
Huang, Shou-Jie;
Pan, Hui-Rong

Publication type:

Article